Tirzepatide was associated with a 16% lower risk for all-cause death compared to dulaglutide (HR: 0.84
*Correspondence: Karma Yeshi, [email protected] This article was submitted to Parasitology Omics, a section of the journal Frontiers in Parasitology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
And could that support your metabolism, appetite or blood sugar control
It is also used in overweight people who may also have diabetes, high blood pressure, high cholesterol, or heart disease
The clinical evidence exists but is limited small trials, older studies, no large RCTs
naltrexone-bupropion targets brain circuits controlling appetite and body temperature